Species difference in the induction of hepatic CYP1A subfamily enzymes, especially CYP1A2, by 2-methoxy-4-nitroaniline among rats, mice, and guinea pigs

被引:12
作者
Souma, Shinji
Sekimoto, Masashi
Degawa, Masakuni
机构
[1] Univ Shizuoka, Dept Mol Toxicol, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
[2] Univ Shizuoka, COE Program 21st Century, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
关键词
2-methoxy-4-nitroaniline; cytochrome P450 induction; CYP1A; species difference;
D O I
10.1007/s00204-006-0103-3
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Species difference in the induction of hepatic cytochrome P450 CYP1A subfamily enzymes by 2-methoxy-4-nitroaniline (2-MeO-4-NA) was investigated among male F344 rats, C57BL/6 Cr mice, and Hartley guinea pigs. All species of animals were treated with a single ip injection of 2-MeO-4-NA (0.44 mmol/kg body weight), and changes in levels of the mRNA and protein of hepatic cytochrome P4501A (CYP1A) subfamily enzymes were examined by the methods of RT-PCR and Western blot, respectively. In addition, hepatic microsomal enzyme activities were measured using methoxyresorufin and ethoxyresorufin as substrates of CYP1A2 and CYP1A1, respectively. The overall results of the RT-PCR, Western blot, and measurement of the enzyme activity indicated that 2-MeO-4-NA-mediated induction of hepatic CYP1A subfamily enzymes, especially CYP1A2, occurred only in rats but not any other species of animals examined and that the species difference in the CYP1A induction was not necessarily correlated with that in pharmacokinetics of 2-MeO-4-NA. Furthermore, a luciferase reporter gene assay for screening of the ligands of arylhydrocarbon receptor (AhR) using a rat hepatic cell line suggested that 2-MeO-4-NA is not an AhR ligand. The present findings demonstrate for the first time the species difference in the 2-MeO-4-NA-mediated induction of hepatic CYP1A subfamily enzymes between rats and other rodents, mice and guinea pigs, and further propose an AhR-independent pathway for 2-MeO-4-NA-mediated induction in rats.
引用
收藏
页码:739 / 747
页数:9
相关论文
共 38 条
[11]   Constitutive expression of cytochrome P450 genes in newly established rat hepatic cell lines [J].
Degawa, M ;
Namiki, M ;
Yoshimoto, N ;
Makino, M ;
Iwamoto, M ;
Nemoto, K ;
Hashimoto, Y .
JOURNAL OF BIOCHEMISTRY, 2003, 133 (06) :825-831
[12]   2-methoxy-4-nitroaniline and its isomers induce cytochrome P4501A (CYP1A) enzymes with different selectivities in the rat liver [J].
Degawa, M ;
Nakayama, M ;
Konno, Y ;
Masubuchi, K ;
Yamazoe, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1998, 1379 (03) :391-398
[13]   HEPATOCARCINOGENIC HETEROCYCLIC AROMATIC-AMINES THAT INDUCE CYTOCHROME-P-448 ISOZYMES, MAINLY CYTOCHROME-P-448H (P-450IA2), RESPONSIBLE FOR MUTAGENIC ACTIVATION OF THE CARCINOGENS IN RAT-LIVER [J].
DEGAWA, M ;
TANIMURA, S ;
AGATSUMA, T ;
HASHIMOTO, Y .
CARCINOGENESIS, 1989, 10 (06) :1119-1122
[14]   SPECIES, SEX AND ORGAN DIFFERENCES IN INDUCTION OF A CYTOCHROME-P-450 ISOZYME RESPONSIBLE FOR CARCINOGEN ACTIVATION - EFFECTS OF DIETARY HEPATOCARCINOGENIC TRYPTOPHAN PYROLYSATE COMPONENTS IN MICE AND RATS [J].
DEGAWA, M ;
HISHINUMA, T ;
YOSHIDA, H ;
HASHIMOTO, Y .
CARCINOGENESIS, 1987, 8 (12) :1913-1918
[15]   2-METHOXY-4-NITROANILINE IS A SELECTIVE INDUCER OF CYTOCHROME P450IA2 (CYP1A2) IN RAT-LIVER [J].
DEGAWA, M ;
NAKAYAMA, M ;
YOSHINARI, K ;
HASHIMOTO, Y .
CANCER LETTERS, 1995, 96 (01) :95-98
[16]   PREDICTIVE STRATEGIES FOR SELECTING 379 NCI NTP CHEMICALS EVALUATED FOR CARCINOGENIC POTENTIAL - SCIENTIFIC AND PUBLIC-HEALTH IMPACT [J].
FUNG, VA ;
HUFF, J ;
WEISBURGER, EK ;
HOEL, DG .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1993, 20 (04) :413-436
[17]  
Gómez-Lechón MJ, 1998, J CELL PHYSIOL, V177, P553, DOI 10.1002/(SICI)1097-4652(199812)177:4<553::AID-JCP6>3.0.CO
[18]  
2-F
[19]   METABOLIC-ACTIVATION OF GLUTAMIC-ACID PYROLYSIS PRODUCTS, 2-AMINO-6-METHYLDIPYRIDO[1,2-A-3',2'-D]IMIDAZOLE AND 2-AMINO-DIPYRIDO[1,2-A-3',2'-D]IMIDAZOLE, BY PURIFIED CYTOCHROME-P-450 [J].
ISHII, K ;
YAMAZOE, Y ;
KAMATAKI, T ;
KATO, R .
CHEMICO-BIOLOGICAL INTERACTIONS, 1981, 38 (01) :1-13
[20]  
KAMATAKI T, 1983, MOL PHARMACOL, V24, P146